147 related articles for article (PubMed ID: 17076562)
1. Complement factor h gene abnormalities in haemolytic uraemic syndrome: from point mutations to hybrid gene.
Noris M; Remuzzi G
PLoS Med; 2006 Oct; 3(10):e432. PubMed ID: 17076562
[TBL] [Abstract][Full Text] [Related]
2. Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.
Chaudhary P; Hepgur M; Sarkissian S; Smith RJ; Weitz IC
Blood Transfus; 2014 Jan; 12(1):111-3. PubMed ID: 24333077
[No Abstract] [Full Text] [Related]
3. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene.
Venables JP; Strain L; Routledge D; Bourn D; Powell HM; Warwicker P; Diaz-Torres ML; Sampson A; Mead P; Webb M; Pirson Y; Jackson MS; Hughes A; Wood KM; Goodship JA; Goodship TH
PLoS Med; 2006 Oct; 3(10):e431. PubMed ID: 17076561
[TBL] [Abstract][Full Text] [Related]
4. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.
Francis NJ; McNicholas B; Awan A; Waldron M; Reddan D; Sadlier D; Kavanagh D; Strain L; Marchbank KJ; Harris CL; Goodship TH
Blood; 2012 Jan; 119(2):591-601. PubMed ID: 22058112
[TBL] [Abstract][Full Text] [Related]
5. Complement factor H and the haemolytic uraemic syndrome.
Taylor CM
Lancet; 2001 Oct; 358(9289):1200-2. PubMed ID: 11675053
[No Abstract] [Full Text] [Related]
6. Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?
Poolpol K; Gadner B; Neururer S; Mellmann A; Karch H; Orth D; Würzner R
Int J Immunogenet; 2011 Oct; 38(5):383-7. PubMed ID: 21649859
[TBL] [Abstract][Full Text] [Related]
7. Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.
Noris M; Remuzzi G
Clin Exp Immunol; 2008 Feb; 151(2):199-209. PubMed ID: 18070148
[TBL] [Abstract][Full Text] [Related]
8. Complement dysregulation in haemolytic uraemic syndrome.
Bonnardeaux A; Pichette V
Lancet; 2003 Nov; 362(9395):1514-5. PubMed ID: 14615103
[No Abstract] [Full Text] [Related]
9. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
Kavanagh D; Richards A; Fremeaux-Bacchi V; Noris M; Goodship T; Remuzzi G; Atkinson JP
Clin J Am Soc Nephrol; 2007 May; 2(3):591-6. PubMed ID: 17699467
[No Abstract] [Full Text] [Related]
10. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries.
Neumann HP; Salzmann M; Bohnert-Iwan B; Mannuelian T; Skerka C; Lenk D; Bender BU; Cybulla M; Riegler P; Königsrainer A; Neyer U; Bock A; Widmer U; Male DA; Franke G; Zipfel PF
J Med Genet; 2003 Sep; 40(9):676-81. PubMed ID: 12960213
[TBL] [Abstract][Full Text] [Related]
11. Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency.
Warwicker P; Donne RL; Goodship JA; Goodship TH; Howie AJ; Kumararatne DS; Thompson RA; Taylor CM
Nephrol Dial Transplant; 1999 May; 14(5):1229-33. PubMed ID: 10344366
[TBL] [Abstract][Full Text] [Related]
12. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts.
Fremeaux-Bacchi V; Kemp EJ; Goodship JA; Dragon-Durey MA; Strain L; Loirat C; Deng HW; Goodship TH
J Med Genet; 2005 Nov; 42(11):852-6. PubMed ID: 15784724
[TBL] [Abstract][Full Text] [Related]
13. Atypical haemolytic uraemic syndrome.
Kavanagh D; Goodship TH; Richards A
Br Med Bull; 2006; 77-78():5-22. PubMed ID: 16968692
[TBL] [Abstract][Full Text] [Related]
14. Varicella as a trigger of atypical haemolytic uraemic syndrome associated with complement dysfunction: two cases.
Kwon T; Belot A; Ranchin B; Baudouin V; Fremeaux-Bacchi V; Dragon-Durey MA; Cochat P; Loirat C
Nephrol Dial Transplant; 2009 Sep; 24(9):2752-4. PubMed ID: 19376828
[TBL] [Abstract][Full Text] [Related]
15. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
Perkins SJ; Goodship TH
J Mol Biol; 2002 Feb; 316(2):217-24. PubMed ID: 11851332
[TBL] [Abstract][Full Text] [Related]
16. A mouse model of non-Shiga toxin-associated haemolytic uraemic syndrome.
Caprioli J; Remuzzi G
Nephrol Dial Transplant; 2008 Feb; 23(2):462-5. PubMed ID: 17956888
[No Abstract] [Full Text] [Related]
17. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.
Manuelian T; Hellwage J; Meri S; Caprioli J; Noris M; Heinen S; Jozsi M; Neumann HP; Remuzzi G; Zipfel PF
J Clin Invest; 2003 Apr; 111(8):1181-90. PubMed ID: 12697737
[TBL] [Abstract][Full Text] [Related]
18. Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS).
Roumenina LT; Roquigny R; Blanc C; Poulain N; Ngo S; Dragon-Durey MA; Frémeaux-Bacchi V
Methods Mol Biol; 2014; 1100():237-47. PubMed ID: 24218264
[TBL] [Abstract][Full Text] [Related]
19. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.
Valoti E; Alberti M; Tortajada A; Garcia-Fernandez J; Gastoldi S; Besso L; Bresin E; Remuzzi G; Rodriguez de Cordoba S; Noris M
J Am Soc Nephrol; 2015 Jan; 26(1):209-19. PubMed ID: 24904082
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H.
Sánchez-Corral P; González-Rubio C; Rodríguez de Córdoba S; López-Trascasa M
Mol Immunol; 2004 May; 41(1):81-4. PubMed ID: 15140578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
